Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
Articolo
Data di Pubblicazione:
2018
Abstract:
Triple negative breast cancer (TNBC) easily develops resistance to the first-line drug doxorubicin, because of the high levels of the drug efflux transporter P-glycoprotein (Pgp) and the activation of pro-survival pathways dependent on endoplasmic reticulum (ER). Interfering with these mechanisms may overcome the resistance to doxorubicin, a still unmet need in TNBC.
Tipologia CRIS:
03A-Articolo su Rivista
Keywords:
CAAT/enhancer binding protein (C/EBP)-β; Calreticulin; Doxorubicin; Endoplasmic reticulum stress; P-glycoprotein; Triple negative breast cancer
Elenco autori:
Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
Link alla scheda completa:
Link al Full Text:
Pubblicato in: